tallózása szerző szerint "Döme Balázs"

1-13 / 13

ANTIANGIOGENIC THERAPY IN ADVANCED LUNG ADENOCARCINOMA: EFFICACY AND KRAS MUTATION AS A PROGNOSTIC BIOMARKER

Ghimessy, Áron Kristóf (2020)
Az EGFR mutáció epidemiológiája tüdő adenocarcinomában: hazai tapasztalatok.

Lohinai Zoltán; Ostoros Gyula; Cserepes Tamás Mihály; Rásó Erzsébet; Tímár József; Döme Balázs; Hegedűs Balázs (2013)
BARD1 serum autoantibodies for the detection of lung cancer

Pilyugin M; Descloux P; Andre PA; Laszlo V; Döme Balázs; Hegedűs, Balázs (2017)

Purpose Currently the screening for lung cancer for risk groups is based on Computed Tomography (CT) or low dose CT (LDCT); however, the lung cancer death rate has not decreased significantly with people undergoing LDCT. ...
Circulating fibrinogen is a prognostic and predictive biomarker in malignant pleural mesothelioma.

Ghanim B; Hoda MA; Klikovits T; Winter MP; Alimohammadi A; Grusch M; Döme Balázs; Arns B; Schenk P; Jakopovic M; Samarzija M; Brcic L; Filipits M; Laszlo Viktoria; Klepetko W; Berger W; Hegedüs Balázs (2014)

Background:To investigate the clinical utility of pretreatment plasma fibrinogen levels in malignant pleural mesothelioma (MPM) patients.Methods:A retrospective multicenter study was performed in histologically proven MPM ...
Claudin-1 Protein Expression Is a Good Prognostic Factor in Non-Small Cell Lung Cancer, but only in Squamous Cell Carcinoma Cases

Moldvay Judit; Fábián Katalin; Jäckel Márta; Németh Zsuzsanna; Bogos Krisztina; Furák József; Tiszlavicz László; Fillinger János; Döme Balázs; Schaff Zsuzsa (2017)

The aim of the study was to investigate the correlation between claudin (CLDN) protein expression and clinicopathological parameters as well as survival in histological subtypes of non-small cell lung cancer. Archived ...
Clinical implications of small cell lung cancer molecular and neuroendocrine subtypes

Megyesfalvi, Zsolt (2023)
Clinical relevance of KRAS mutational status and tumor location in bone-metastatic lung adenocarcinoma

Radeczky, Péter (2022)
Evaluating the significance of density, localization, and PD-1/PD-L1 immunopositivity of mononuclear cells in the clinical course of lung adenocarcinoma patients with brain metastasis.

Téglási Vanda; Reiniger Lilla; Fábián Katalin; Pipek Orsolya Anna; Csala Irén; Bagó G Attila; Várallyai Péter; Vízkeleti Laura; Rojkó Lívia; Tímár József; Döme Balázs; Szállási Zoltán; Charles Swanton; Moldvay Judit (2017)
KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS-mutation and bone metastasis

Lohinai Zoltán; Klikovits Thomas; Moldvay Judit; Ostoros Gyula; Rásó Erzsébet; Tímár József; Fábián Katalin; Kovalszky Ilona; Kenessey István; Aigner C; Rényi-Vámos Ferenc István; Klepetko W; Döme Balázs; Hegedűs Balázs (2017)
Massive Withdrawal Symptoms and Affective Vulnerability Are Associated with Variants of the CHRNA4 Gene in a Subgroup of Smokers

Lazáry Judit; Döme Péter; Csala Irén; Kovacs G; Faludi Gábor; Kaunisto M; Döme Balázs (2014)
Renal Impairment Hampers Bisphosphonate Treatment in a Quarter of Lung Cancer Patients with Bone Metastasis

Fábián Katalin; Puskas Rita; Kakuk Tímea; Prés László; Fejes Dorottya; Szegedi Zsolt; Rojkó Lívia; Szállási Zoltán; Döme Balázs; Pipek Orsolya; Moldvay Judit (2018)

Renal function impairment in lung cancer patients with bone metastases was investigated, as this can limit the application of bisphosphonates representing the gold standard in the management of such cases. Clinicopathological ...
The evidence for and against different modes of tumour cell extravasation in the lung: diapedesis, capillary destruction, necroptosis and endothelialisation.

Paku Sándor; László Viktória; Dezső Katalin; Nagy Péter; Hoda, Mir Alireza; Klepetko, Walter; Rényi-Vámos Ferenc; Tímár József; Reynolds, Andrew R.; Döme Balázs (2017)

The development of lung metastasis is a significant negative prognostic factor for cancer patients. The extravasation phase of lung metastasis involves interactions of tumour cells with the pulmonary endothelium. These ...
The plasma membrane Ca2+ pump PMCA4b inhibits the migratory and metastatic activity of BRAF mutant melanoma cells

Hegedűs Luca; Garay Tamás; Molnár Eszter; Varga Karolina; Bilecz Ágnes; Török Szilvia; Padányi Rita; Pászty Katalin; Matthias Wolf; Michael Grusch; Kállay Enikő; Döme Balázs; Berger Walter; Hegedüs Balázs; Enyedi Ágnes (2017)

Oncogenic mutations of BRAF lead to constitutive ERK activity that supports melanoma cell growth and survival. While Ca2+ signaling is a well-known regulator of tumor progression, the crosstalk between Ca2+ signaling and ...

1-13 / 13

Keresés

Összetett keresés

Tallózás

Teljes repozitórumban

Hozzáférésem

Bejelentkezés

tallózása szerző szerint "Döme Balázs"

DSpace/Manakin Repository

tallózása szerző szerint "Döme Balázs"

Keresés

Tallózás

Teljes repozitórumban

Hozzáférésem